Sanofi Starts Bidding Process to Sell Consumer Health Division, Bloomberg Reports

-- Sanofi is seeking buyers for its consumer health arm as it simultaneously plans to potentially list the unit, Bloomberg reported, citing unnamed sources. -- The French pharmaceutical giant set a m

WSJJun 26 15:00

Biggest Stock Movers Today: BB, MU, and More

Seeking Alpha38minutes ago

Regeneron, Sanofi Eosinophilic Esophagitis Treatment Showed Improvements for Children in Phase 3 Study

Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) said Wednesday that a phase 3 trial showed that a greater proportion of children with eosinophilic esophagitis receiving their drug Dupixent showed "s

MT Newswires16:52

Express News | Vigil Neuroscience Shares up 13% at $4.27 Premarket After Co Receives $40 Million Investment From Sanofi

Breakings16:11

Vigil: Program Includes Clinical Candidate VG-3927, Being Evaluated in Phase 1 Study for Alzheimer's >VIGL

Vigil: Program Includes Clinical Candidate VG-3927, Being Evaluated in Phase 1 Study for Alzheimer's >VIGL

Dow Jones14:08

Vigil Neuroscience Is a Clinical-Stage Biotechnology Company >VIGL

Vigil Neuroscience Is a Clinical-Stage Biotechnology Company >VIGL

Dow Jones14:08